Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorNICOLAS, Celine
hal.structure.identifierUniversity of California [Riverside] [UC Riverside]
hal.structure.identifierUniversity of Maryland School of Medicine
dc.contributor.authorZLBNIK, Natalie E.
hal.structure.identifierNational Institutes of Health
hal.structure.identifierNational Institute on Alcohol Abuse and Alcoholism
dc.contributor.authorFAROKHNIA, Mehdi
hal.structure.identifierNational Institutes of Health
hal.structure.identifierNational Institute on Alcohol Abuse and Alcoholism
dc.contributor.authorLGGIO, Lornzo
hal.structure.identifierNational Institutes of Health
dc.contributor.authorIKMOTO, Satoshi
hal.structure.identifierNational Institutes of Health
dc.contributor.authorSHAHAM, Yavin
dc.date.accessioned2023-05-09T15:49:14Z
dc.date.available2023-05-09T15:49:14Z
dc.date.created2022
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/174380
dc.description.abstractEnA widely held dogma in the preclinical addiction field is that females are more vulnerable than males to drug craving and relapse. Here, we first review clinical studies on sex differences in psychostimulant and opioid craving and relapse. Next, we review pre-clinical studies on sex differences in psychostimulant and opioid reinstatement of drug seeking after extinc-tion of drug self-administration, and incubation of drug craving (time-dependent increase in drug seeking during abstinence). We also discuss ovarian hormones’ role in relapse and craving in humans and animal models and speculate on brain mechanisms underlying their role in cocaine craving and relapse in rodent models. Finally, we discuss imaging studies on brain responses to cocaine cues and stress in men and women. The results of the clinical studies reviewed do not appear to support the notion that women are more vulnerable to psychostimulant and opioid craving and relapse. However, this conclusion is tentative because most of the studies reviewed were correlational, not suffi-ciently powered, and not a priori designed to detect sex differences. Additionally, imaging studies suggest sex differences in brain responses to cocaine cues and stress. The results of the preclinical studies reviewed pro-vide evidence for sex differences in stress-induced reinstatement and incubation of cocaine craving but not cue-or cocaine-induced reinstatement of cocaine seeking. These sex differences are modulated in part by ovarian hormones. In contrast, the available data do not support the notion of sex differences in craving and relapse/reinstatement for methamphetamine or opioids in rodent models. Significance Statement——This systematic review summarizes clinical and preclinical studies on sex differences in psychostimulant and opioid craving and relapse. Results of the clinical studies reviewed do not appear to support the notion that women are more vulnerable to psychostimulant and opioid craving and relapse. Results of preclinical studies reviewed pro-vide evidence for sex differences in reinstatement and incubation of cocaine seeking but not for reinstatement or incubation of methamphetamine or opioid seeking. © 2022, American Society for Pharmacology and Experimental Therapy. All rights reserved.
dc.language.isoENen_US
dc.subject.enAnalgesics
dc.subject.enOpioid
dc.subject.enAnimals
dc.subject.enCocaine
dc.subject.enCocaine-Related Disorders
dc.subject.enCraving
dc.subject.enExtinction
dc.subject.enPsychological
dc.subject.enFemale
dc.subject.enHumans
dc.subject.enMale
dc.subject.enRecurrence
dc.subject.enSelf Administration
dc.subject.enSex Characteristics
dc.title.enSex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical ReviewS
dc.title.alternativePharmacol Reven_US
dc.typeDocument de travail - Pré-publicationen_US
dc.identifier.doi10.1124/pharmrev.121.000367en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed34987089en_US
bordeaux.page119en_US
bordeaux.hal.laboratoriesNeurocentre Magendie - U1215en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamCircuits Neuronaux de l'Anxiétéen_US
bordeaux.identifier.funderIDNational Institute on Drug Abuseen_US
bordeaux.identifier.funderIDOffice of Research Infrastructure Programs, National Institutes of Healthen_US
bordeaux.identifier.funderIDFondation pour la Recherche Médicaleen_US
hal.identifierhal-04093097
hal.version1
hal.date.transferred2023-05-09T15:49:22Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.spage=119&rft.epage=119&rft.au=NICOLAS,%20Celine&ZLBNIK,%20Natalie%20E.&FAROKHNIA,%20Mehdi&LGGIO,%20Lornzo&IKMOTO,%20Satoshi&rft.genre=preprint


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée